The FDA has a campaign called BeSafeRx: Know Your Online Pharmacy to raise awareness of the dangers of buying medicines from fake online pharmacies and to provide resources to help US consumers buy safely.
Here is what the FDA highlights in one of their their videos
About buying Medicine online
- You may get a fake drug, with the wrong ingredients
- Your condition may get worse
- You may experience a bad reaction
About learning how to be Safe
- Identify signs of a fraudulent pharmacy
- Get a prescription
- Get to know your online pharmacy and only buy from a legal one
- Take medicine as directed
- Although there are many legitimate online pharmacies, others aren’t licensed in the United States — and some aren’t pharmacies at all. So while buying prescriptions online can save time and even money, it’s important to be selective about which sites to use. Even though I think it is an important campaign as a DES Daughter victim of the biggest drug scandal, I just find it slightly ironic … Whether you buy online or offline, is taking prescription drugs ever safe? Think twice before taking any prescription drugs and be aware of all the side effects.
- Watch our DES Videos in English Playlist on
Posted by DES Daughter on 07/05/2013
The Pill of Truth
If there was one pill that I wish the FDA would approve it would be this one …
Read The Truth about Diethylstilbestrol
by John Krueger
May 9, 2012
Posted by DES Daughter on 07/05/2013
The FDA now states that BPA is “safe” at the exposure level listed on current product packaging
Despite countless scientific evidence explaining the dangers of Bisphenol-A (BPA), the Food and Drug Administration (FDA) refuses to ban this highly profitable industrial chemical.
In their “current perspective on BPA the FDA now states that the chemical is safe at the exposure level listed on current product packaging.
In her post FDA declares BPA exposure is safe! Don’t worry about gender-bender chemicals, Lance Devon covers:
- BPA – wreaking havoc on hormones
- Infertility and hysterectomy on the rise
- FDA’s wobbly stance on BPA cannot be trusted
- Fish are losing their gender and species identity
- Stop BPA before it depopulates the planet
Posted by DES Daughter on 25/04/2013
Discovering and regulating DES by Nancy Langston
- Abstract -
” Rates of intersexuality, reproductive cancers, and infertility appear to be increasing. Many researchers suspect that a key role is played by endocrine disruptors - the industrial pollutants that mimic hormones and disrupt the endocrine systems that shape sexual development.
Yet, for all the concern raised by a flood of experimental research showing endocrine disruption in animals and epidemiological studies suggesting effects on human reproduction, the U.S. government has essentially failed to regulate these chemicals, retreating from a precautionary principle that would require caution in the use of potentially toxic chemicals. Debates in the 1930s and 1940s over the regulation of diethylstilbestrol (DES), the first synthetic estrogen and the first chemical known to act as an endocrine disruptor, show how political pressures, scientific uncertainty, and changing conceptual models of gender and health led to this retreat from precaution “.
Sources © Copyright 2004 by Environmental History
The Retreat from Precaution: Regulating Diethylstilbestrol (DES), Endocrine Disruptors, and Environmental Health by Nancy Langston
Professor of environmental studies and forestry
From the same author:
Toxic Bodies: Hormone Disruptors and the Legacy of DES
Posted by DES Daughter on 21/04/2013
The diethylstilbestrol tragedy: a failure of oversight or poor science?
For a thorough historical review of the DES tragedy take a moment and read this lengthy call for tighter FDA regulation of the drug industry. The DES story makes a compelling case!
DES Action USA commented: “ Thank you for this call for stronger government regulation of pharmaceuticals. The DES tragedy makes a compelling case and you tell the story well. Adding insult to injury, it isn’t correct to say that in 1971 the FDA banned DES for most uses. Sadly, DES was only ‘contraindicated’ so it was well into the 1970s before doctors stopped prescribing DES to pregnant women! Either they didn’t get the word, or they felt they knew better than government regulators. Many doctors now dismiss DES exposure as ‘not a problem anymore’ but millions of us were exposed before birth and live with the health problems it caused. We fervently wish similar tragedies wouldn’t happen again – but sadly, the DES lessons learned are being ignored. “
Read Problems in Research: Regulations—The Diethylstilbestrol Tragedy
Posted by DES Daughter on 15/04/2013
Toxic Bodies: Hormone Disruptors and the Legacy of DES on Flickr
In 1941 the FDA approved diethylstilbestrol use. In this gripping exploration, Nancy Langston shows how these chemicals have penetrated into every aspect of our bodies and ecosystems, yet the U.S. government has largely failed to regulate them and has skillfully manipulated scientific uncertainty to delay regulation. Personally affected by endocrine disruptors, Professor Langston argues that the FDA needs to institute proper regulation of these commonly produced synthetic chemicals.
Posted by DES Daughter on 15/04/2013
” The chemical bisphenol A (BPA) has been linked to cancer and other diseases, yet we are continually exposed to it in our daily lives… The US FDA has the power to act on behalf of the health and safety of the American people. By banning BPA from all food and drink products and packages, the Dr. Hamburg, the head of the FDA, can protect Americans from unwittingly consuming a dangerous chemical. Please sign this petition and get your networks involved to urge the FDA to completely ban BPA. “
Take action: The Petition Site
Posted by DES Daughter on 27/03/2013
“ Most people don’t realize that to garner FDA approval, a drug company only has to show the medication is better than nothing and the benefit outweighs harm… …The initial studies are also often conducted over a short period of time – usually six months.”
says Steven Woloshin, MD, professor of medicine at Dartmouth Institute for Health Policy and Clinical Practice.
Read The Truth about Prescription Drugs by Lara Rosenbaum
Posted by DES Daughter on 20/03/2013
How Drug Companies mislead Doctors and harm Patients
From amazon.co.uk : “ Ben Goldacre puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess.
Doctors and patients need good scientific evidence to make informed decisions. But instead, companies run bad trials on their own drugs, which distort and exaggerate the benefits by design. When these trials produce unflattering results, the data is simply buried. All of this is perfectly legal. In fact, even government regulators withhold vitally important data from the people who need it most. Doctors and patient groups have stood by too, and failed to protect us. Instead, they take money and favours, in a world so fractured that medics and nurses are now educated by the drugs industry. Patients are harmed in huge numbers.
Ben Goldacre is Britain’s finest writer on the science behind medicine, and ‘Bad Pharma’ is a clear and witty attack, showing exactly how the science has been distorted, how our systems have been broken, and how easy it would be to fix them. “
What about DES, the FDA and Eli Lilly?
It is Time for Actions: did you SIGN THE PETITION ?
Posted by DES Daughter on 15/03/2013
” Using data drawn from queries entered into Google, Microsoft and Yahoo search engines, scientists at Microsoft, Stanford and Columbia University have for the first time been able to detect evidence of unreported prescription drug side effects before they were found by the Food and Drug Administration’s warning system. “
Read Unreported Side Effects of Drugs Are Found Using Internet Search Data, Study Finds by John Markoff
Posted by DES Daughter on 12/03/2013